Cytokine and chemokine production in AML is known to be induced by the activation of MAP kinase pathways, and through silencing of FBXO21 in AML, we have observed modulation of the MAP kinase pathway, ERK1/2. Here, MAPK3 is linked to acute myeloid leukemia.